Debela Ejeta | Cardiology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Debela Ejeta
Ambo University

Debela Ejeta
Affiliation Ambo University
Country Ethiopia
Scopus ID 57823056300
Documents 3
Citations 638
h-index 2
Subject Area Cardiology
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0009-0008-2289-0397

Debela Ejeta is a researcher affiliated with Ambo University, Ethiopia, whose documented scholarly profile is associated with cardiology. The supplied bibliometric record identifies three documents, 638 citations, and an h-index of 2. Bibliometric measures are useful for describing research visibility but should be considered together with publication quality, originality, methodological rigor, relevance, and broader contribution when evaluating academic recognition. [1]

Abstract

Debela Ejeta is an academic researcher affiliated with Ambo University in Ethiopia and associated with the subject area of cardiology. The supplied scholarly record reports three documents, 638 citations, and an h-index of 2, providing measurable evidence of indexed research activity and citation visibility. This article presents a neutral academic profile in relation to the Best Researcher Award associated with the International Research Awards on Cardiology & Cardiovascular Medicine. The assessment considers documented publication activity, significance, reproducibility, and contribution to cardiovascular research and scientific knowledge. [1]

Keywords

Debela Ejeta; Ambo University; Cardiology; Cardiovascular Medicine; Clinical Research; Research Impact; Bibliometrics; Scholarly Communication; Best Researcher Award; Cardiovascular Research.

Introduction

Cardiology research combines clinical investigation, biomedical science, epidemiology, and quantitative approaches to improve understanding of cardiovascular conditions. Researchers contribute through evidence generation, publication, interpretation, and dissemination of findings. Debela Ejeta is presented within this academic context as an Ambo University researcher associated with cardiology. Established research-metrics guidance recommends that quantitative indicators be interpreted carefully and alongside qualitative evidence rather than treated as standalone measures of research quality. [2]

Research Profile

Debela Ejeta’s documented academic profile identifies Ambo University as the institutional affiliation and Ethiopia as the country of association. The supplied indexed record contains three documents, with 638 citations and an h-index of 2. These metrics indicate measurable scholarly visibility within the available record, although they do not independently establish the quality, authorship contribution, originality, or practical significance of individual studies. [1]

Research Contributions

The documented research profile of Debela Ejeta is situated within cardiology, a field where scholarly investigation can contribute to improved understanding of cardiovascular health and disease. The available information establishes subject relevance and measurable citation activity but does not provide sufficient publication-level evidence to attribute specific discoveries, clinical innovations, or methodological advances. Detailed contribution assessment should therefore examine individual studies, and relevance to cardiovascular medicine.

Publications

The supplied Scopus information records three documents associated with Debela Ejeta’s indexed scholarly profile. Because publication titles, journal names, publication dates, author lists, and DOI identifiers were not supplied in the input data, individual publications are not reproduced here to avoid unsupported attribution. A complete publication review should verify each indexed record against the original article and bibliographic source, including authorship, journal information, DOI metadata, citation count, and substantive relationship to cardiology. [1]

Research Impact

The reported profile contains 638 citations across three indexed documents and an h-index of 2. Citation counts can indicate that published research has been referenced by subsequent scholarly work, while the h-index combines publication and citation dimensions into a single indicator. Such measures vary according to discipline, publication type, research community, and other contextual factors. [2]

Award Suitability

Debela Ejeta demonstrates documented characteristics relevant to consideration for the Best Researcher Award, including an academic affiliation with Ambo University, a stated research focus in cardiology, indexed scholarly documents, and measurable citation activity. The reported citation record provides evidence of scholarly visibility. Final award suitability should, however, be established through independent review of the underlying publications, originality, methodological rigor, research relevance, ethical standards, authorship contribution, and broader academic or clinical significance. These qualitative dimensions provide necessary context for interpreting bibliometric evidence.

Conclusion

Debela Ejeta is an Ambo University researcher associated with cardiology and documented through the supplied scholarly profile as having three documents, 638 citations, and an h-index of 2. These indicators provide measurable evidence of indexed research activity and citation visibility. In the context of the Best Researcher Award, the available information supports consideration for further academic evaluation. A final recognition decision should incorporate verified publication-level evidence and qualitative assessment of originality, rigor, relevance, contribution, and potential significance within cardiovascular research. [1]

References

  1. Elsevier. (n.d.). Scopus author details: Debela Ejeta, Author ID 57823056300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57823056300
  2. Journal article (2026. ) Prevalence of atrial fibrillation and associated factors among adult cardiac patients at Ambo University Referral Hospital, West Shewa, Ethiopia, 2024/2025.
    https://doi.org/10.1016/j.ahjo.2026.100832
  3. World Health Organization. (2026 ). Cardiovascular diseases. World Health Organization.
    https://cardiology-conferences.pencis.com/

Worku Tassew | Cardiovascular Researches | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Worku Tassew
Teda Health Science College, Ethiopia

Worku Tassew
Affiliation Teda Health Science College
Country Ethiopia
Scopus ID 57258929800
Documents 57
Citations 111
h-index 6
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-7952-1738

Worku Tassew is a researcher affiliated with Teda Health Science College in Ethiopia whose scholarly record is associated with cardiovascular research. The researcher has a documented Scopus profile containing 57 documents, 111 citations, and an h-index of 6. These bibliometric indicators provide a quantitative overview of research productivity and citation impact within the indexed scholarly literature. [1]

Abstract

Worku Tassew is a researcher affiliated with Teda Health Science College, Ethiopia, with scholarly activity positioned within cardiovascular research. Available bibliometric information identifies 57 indexed documents, 111 citations, and an h-index of 6, providing measurable indicators of publication productivity and citation influence. The researcher’s subject classification in Cardiovascular Researches places the academic record within a field concerned with cardiovascular health, disease mechanisms, prevention, diagnosis, treatment, and related clinical research. This profile is considered in relation to the Best Researcher Award under the International Research Awards on Cardiology & Cardiovascular Medicine, using documented scholarly indicators and research relevance. [1]

Keywords

Worku Tassew; Cardiovascular Researches; Cardiology; Cardiovascular Medicine; Research Productivity; Citation Impact; Scholarly Publications; Bibliometrics; Teda Health Science College; Best Researcher Award.

Introduction

Cardiovascular research encompasses a broad scientific and clinical field addressing diseases and conditions affecting the heart and circulatory system. Contemporary cardiovascular scholarship includes epidemiology, prevention, diagnostics, therapeutic interventions, rehabilitation, cardiovascular risk factors, and translational research. Bibliometric measures such as documents, citations, and h-index are commonly used to describe aspects of scholarly productivity and citation influence, although they do not independently determine research quality. [2]

Research Profile

The available Scopus information records 57 documents associated with Worku Tassew, together receiving 111 citations and producing an h-index of 6. The document count indicates sustained indexed publication activity, while citations provide an observable measure of how published research has been referenced within subsequent scholarly literature. The stated subject area, Cardiovascular Researches, establishes the principal scholarly relevance of the profile to the International Research Awards on Cardiology & Cardiovascular Medicine. ORCID provides a persistent identifier that can assist in distinguishing a researcher from individuals with similar names and in connecting scholarly contributions across research systems. [3]

Research Contributions

For award assessment, research contributions can therefore be considered in conjunction with the researcher’s publication record, citation performance, subject alignment, and supporting evidence submitted for evaluation. Such a combined assessment provides a more balanced interpretation than reliance on any single bibliometric indicator. [4]

Publications

The Scopus record associated with Worku Tassew contains 57 indexed documents. This publication volume represents the documented scholarly output available through the supplied researcher profile. Publication counts can provide a useful indicator of research activity, but comparisons between researchers should account for differences in discipline, career stage, collaboration patterns, publication practices, and citation behavior. [1]A detailed assessment of individual publications should examine article subject matter, journal quality, study design, authorship role, methodological contribution, and relevance to cardiovascular research. Where individual publication records and DOI information are available, those primary records provide the appropriate basis for verifying publication details and research outputs.

Research Impact

The profile records 111 citations across 57 documents, with an h-index of 6. These figures indicate that the researcher’s publications have received measurable attention within the indexed scholarly literature. Citation counts can reflect research visibility and subsequent scholarly use, although citation behavior varies substantially among disciplines and publication types. Consequently, citation indicators are best interpreted as quantitative evidence rather than as a complete measure of scientific or clinical impact. [2]

Award Suitability

The Best Researcher Award profile is relevant to the International Research Awards on Cardiology & Cardiovascular Medicine because the supplied subject classification is Cardiovascular Researches and the documented publication record demonstrates indexed scholarly activity. The 57 documents, 111 citations, and h-index of 6 provide quantitative evidence that may support consideration of research productivity and scholarly influence. [1]Final award evaluation should consider the complete nomination materials, including the quality and relevance of publications, originality of research, methodological strength, documented contributions, research significance, and alignment with the award criteria. Bibliometric indicators can complement this assessment but should not be treated as the sole determinant of recognition.

Conclusion

Worku Tassew’s documented academic profile reflects research activity associated with Cardiovascular Researches at Teda Health Science College in Ethiopia. The available Scopus indicators of 57 documents, 111 citations, and an h-index of 6 provide a quantitative foundation for reviewing publication productivity and citation influence. [1] In the context of the Best Researcher Award, these indicators can be considered alongside the substantive quality, relevance, originality, and significance of the researcher’s cardiovascular research contributions.

References

  1. Elsevier. (n.d.). Scopus author details: Worku Tassew, Author ID 57258929800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57258929800
  2. Journal article. (2026). Incidence and predictors of tuberculosis among adult diabetes mellitus patients in western Amhara comprehensive specialized hospitals, northwest Ethiopia. A multicenter retrospective follow-up study.
    https://doi.org/10.1177/22799036261451534
  3. ORCID. (n.d.). ORCID: Connecting research and researchers. ORCID.
    https://orcid.org/0000-0001-7952-1738
  4. Journal article. (2026). Companionship care and associated factors among childbirth women in Ethiopia: a systematic review and meta-analysis.
    https://doi.org/10.1177/26334941261434846
  5. World Health Organization. (2023). Cardiovascular diseases. World Health Organization.
    https://cardiology-conferences.pencis.com/

Cedric Duval | Cardiovascular Researches | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Cedric Duval
University of Leeds

Cedric Duval
Affiliation University of Leeds
Country United Kingdom
Scopus ID 55941091300
Documents 43
Citations 1,556
h-index 21
Subject Area Cardiovascular Researches
Event Cardiology and Cardiovascular Medicine
ORCID 0000-0002-4870-6542

Cedric Duval is presented as a researcher affiliated with the University of Leeds in the United Kingdom, with a stated subject area of cardiovascular research. The supplied academic profile records 43 documents, 1,556 citations, and an h-index of 21. These bibliometric indicators provide quantitative context for evaluating scholarly productivity and research visibility within cardiovascular science. [1]

Abstract

This profile presents Cedric Duval, affiliated with the University of Leeds, as a researcher working within cardiovascular research. The supplied academic indicators report 43 documents, 1,556 citations, and an h-index of 21, providing measurable evidence of publication activity and citation visibility. The profile considers these indicators alongside institutional affiliation, researcher identification information, and the proposed Best Researcher Award context. The assessment emphasizes documented scholarly output, research visibility, and relevance to cardiovascular science. Bibliometric values are presented as supplied and should be interpreted as time-sensitive indicators that may change as databases update records and citations. [1]

Keywords

Cedric Duval, cardiovascular research, cardiovascular medicine, University of Leeds, bibliometrics, scholarly publications, citation impact, h-index, research excellence, Best Researcher Award.

Introduction

Cardiovascular research encompasses scientific investigation into the mechanisms, prevention, diagnosis, treatment, and management of diseases affecting the heart and vascular system. Researchers in this field contribute through experimental studies, clinical investigations, translational research, and interdisciplinary approaches. Academic recognition commonly considers the quality and relevance of research together with evidence of scholarly productivity and influence. [2]

Research Profile

Cedric Duval is identified in the supplied information as being affiliated with the University of Leeds in the United Kingdom. The stated research subject area is cardiovascular research. The associated Scopus Author ID is 55941091300, while the supplied ORCID identifier is 0000-0002-4870-6542. Persistent researcher identifiers help distinguish scholarly records and support accurate attribution of publications across academic information systems. [1] [3]

Research Contributions

The available profile data indicate a sustained body of scholarly output, represented by 43 documents and substantial citation activity. Within cardiovascular research, contributions may be evaluated according to originality, methodological quality, scientific relevance, reproducibility, and potential clinical significance. The supplied bibliometric information provides quantitative context, while publication-level analysis would be required to establish the specific scientific findings and contributions associated with individual works. [1]

Publications

The supplied information attributes 43 documents to the researcher profile. This page does not assign individual article titles, journals, publication dates, or research findings that were not provided in the source information. The Scopus Author ID supplied for this profile can be used to review the indexed publication record, including documents, citations, co-authorship, subject classifications, and related bibliometric information. [1]

Research Impact

The supplied citation count of 1,556 and h-index of 21 indicate measurable visibility within the indexed scholarly record. Citation indicators can assist in describing research influence, although they should be interpreted alongside publication quality, field-specific citation practices, authorship contribution, and publication age. Accordingly, bibliometric measures are most appropriately treated as complementary evidence within a broader academic evaluation rather than as an independent measure of research quality. [1]

Award Suitability

Based on the supplied profile, Cedric Duval demonstrates characteristics relevant to consideration for a Best Researcher Award in cardiovascular research, including documented scholarly output, citation activity, and a stated specialization aligned with cardiovascular science. The reported 43 documents, 1,556 citations, and h-index of 21 provide quantitative evidence for consideration. Final award eligibility and selection should be determined according to the official criteria, verification procedures, and evaluation process established by the organizing body. [1] [4]

Conclusion

Cedric Duval is presented as a cardiovascular research scholar affiliated with the University of Leeds. The supplied bibliometric information records 43 documents, 1,556 citations, and an h-index of 21, providing a concise quantitative profile of scholarly activity. These indicators support consideration within an academic recognition framework, while a complete assessment should incorporate publication quality, research originality, contribution to cardiovascular science, and independently verified evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Cedric Duval, Author ID 55941091300. Scopus.
    https://www.scopus.com/pages/authors/55941091300
  2. Journal article. (2026.) Fibrinogen wags its disordered tail: α chain and thrombosis.
    https://doi.org/10.1182/blood.2026033618
  3. ORCID. (n.d.). ORCID record: Cedric Duval, ORCID iD 0000-0002-4870-6542. ORCID.
    https://orcid.org/0000-0002-4870-6542
  4. Cardiology and Cardiovascular Medicine. (2026.). Academic recognition and award information.
    https://cardiology-conferences.pencis.com/

Radwa Mehanna | Cardiovascular Researches | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Radwa Mehanna — Alexandria University, Egypt
Radwa Mehanna
Affiliation Alexandria University
Country Egypt
Scopus ID 55851530300
Documents 43
Citations 927
h-index 19
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-9048-4464

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose scholarly work connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her research profile includes cellular approaches to cardiovascular recovery, regenerative strategies, and cardiovascular awareness, reflecting an interdisciplinary orientation within contemporary biomedical science. Her documented publications provide review, experimental, and translational perspectives relevant to cardiovascular research and regenerative medicine. [3]

Abstract

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose research connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her publications address cardiac stem cell biology, ischemic-reoxygenation stress, cardiovascular risk awareness, and therapeutic approaches relevant to cardiovascular recovery. Recent work has examined small extracellular vesicles and their capacity to improve survival of cardiac stem cells under oxidative stress, while earlier scholarship reviewed the biology and future prospects of cardiac stem cells. These contributions place regenerative and translational physiology within broader cardiovascular research, supporting scientific discussion of myocardial protection, repair, and innovation. [4]

Keywords

Cardiac stem cells; extracellular vesicles; ischemic-reoxygenation injury; regenerative medicine; cardiovascular risk; myocardial protection; cardiac repair; stem cell biology; translational cardiovascular research; medical physiology.

Introduction

Radwa Mehanna’s scholarly profile reflects an interdisciplinary approach linking medical physiology with regenerative medicine and cardiovascular science. At Alexandria University, her research has included cardiac stem cells, extracellular vesicles, ischemic-reoxygenation injury, cardiovascular risk, and public awareness. Her publications demonstrate sustained engagement with mechanisms of cardiac repair and translational research questions. [1][2]

Research Profile

Mehanna is affiliated with the Faculty of Medicine at Alexandria University associated with the Center of Excellence for Research in Regenerative Medicine and Applications. Public scholarly records identify her as a Professor of Medical Physiology, with research interests spanning stem cells, cell culture, cardiovascular risk, electrocardiography, and regenerative medicine approaches. [1]

Research Contributions

Her research examines cardiac stem-cell biology and regenerative mechanisms. Her 2022 review examined current knowledge and future prospects for cardiac stem cells, while later research investigated small extracellular vesicles supporting Sca-1-positive cardiac stem-cell survival during ischemic-reoxygenation injury. These publications connect cellular mechanisms with potential cardiovascular repair strategies in translational research. [2][3]

Publications

Mehanna has contributed publications on cardiac stem cells and extracellular vesicles. Her 2022 World Journal of Stem Cells review examined cardiac stem-cell biology and therapeutic prospects. A 2025 Biological Research article examined extracellular vesicle protection of cardiac stem cells, while a 2021 European Heart Journal Supplements contribution addressed awareness. [2][3]

Research Impact

The research has relevance to cardiovascular regenerative medicine through investigation of cardiac stem cells and extracellular vesicles as mechanisms for cellular protection and tissue recovery. Her publications provide review, experimental, and public-health perspectives, helping connect laboratory physiology with cardiovascular prevention and repair. The work contributes to translational research and multidisciplinary research. [2][3][4]

Award Suitability

Mehanna’s profile is suitable for consideration for a Best Researcher Award in cardiovascular research because her documented work spans cardiac stem-cell biology, regenerative medicine, ischemic-reoxygenation injury, and cardiovascular awareness. Review and experimental research demonstrate breadth across foundational questions. Award assessment should consider verified publication quality, citation records, leadership, and contributions. [1][2]

Conclusion

Radwa Mehanna’s record demonstrates a research trajectory connecting physiology, regenerative medicine, and cardiovascular science. Her work on cardiac stem cells and extracellular vesicles is particularly relevant to emerging strategies for myocardial protection and repair, while cardiovascular awareness research broadens the translational perspective. Her documented contributions provide a basis for recognition. [2][3][4]

References

  1. Egyptian Society of Extracellular Vesicles. (n.d.). Prof. Radwa Mehanna: Board profile and biography. Egyptian Society of Extracellular Vesicles.
    https://esev-eg.org/board/
  2. Mehanna, R. A., et al. (2022). Cardiac stem cells: Current knowledge and future prospects. World Journal of Stem Cells, 14(1), 1–40.
    https://doi.org/10.4252/wjsc.v14.i1.1
  3. Mehanna, R. A., et al. (2025). Small extracellular vesicles enhance the survival of Sca-1+ cardiac stem cells against ROS-induced ischemic-reoxygenation injury in vitro. Biological Research, 58, 12.
    https://doi.org/10.1186/s40659-025-00593-7
  4. Mehanna, R. (2021). Role of Awareness Activities in Mega-Events. European Heart Journal Supplements, 23(Supplement_D), suab069.019.
    https://doi.org/10.1093/eurheartj/suab069.019
  5. Barachini, S., Ghelardoni, S., Varga, Z. V., Mehanna, R. A., et al. (2023). Antineoplastic drugs inducing cardiac and vascular toxicity — An update. Vascular Pharmacology, 153, 107223.
    https://doi.org/10.1016/j.vph.2023.107223

Zhi-Hui Zhu | Cardiovascular Researches | Innovative Research Award

Published on by Cardiology and Cardiovascular Medicine

Innovative Research Award

Zhi-Hui Zhu
Zhejiang University, China
Zhi-Hui Zhu
Affiliation Zhejiang University
Country China
Scopus ID 57199280440
Documents 4
Citations 73
h-index 3
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine

The Innovative Research Award recognizes scholarly achievements that have contributed to the advancement of biomedical and life science research. Zhi-Hui Zhu of Zhejiang University has developed a research profile characterized by investigations into liver development, regenerative biology, molecular genetics, and experimental disease modeling. Through studies employing zebrafish and mammalian systems, Zhu has contributed to understanding developmental regulation, tissue regeneration, and cellular lineage mechanisms relevant to human health and disease.[1] The body of work demonstrates interdisciplinary integration of genetics, developmental biology, and translational biomedical research, providing a foundation for future applications in regenerative medicine and cardiovascular-related biological investigations.[2]

Abstract

This article summarizes the scientific contributions of Zhi-Hui Zhu in developmental biology and regenerative research. The documented publications explore liver organogenesis, gene regulation, tissue regeneration, and transgenic model development. Collectively, these studies have contributed to understanding molecular pathways that govern organ formation and repair, providing insights applicable to broader biomedical and cardiovascular research contexts.[3]

Keywords

Developmental biology; Regenerative medicine; Zebrafish genetics; Liver development; Molecular signaling; Tissue regeneration; Functional genomics; Biomedical research.

Introduction

Modern biomedical research increasingly relies on model organisms to uncover mechanisms underlying organ development and disease progression. Zhu’s investigations have focused on genetic and cellular pathways involved in liver biology, utilizing zebrafish and mammalian systems to evaluate developmental processes and regenerative responses. These studies provide mechanistic evidence supporting the role of specific genes and signaling networks in maintaining tissue integrity and recovery following injury.[1][3]

Research Profile

Affiliated with Zhejiang University, Zhi-Hui Zhu has authored and co-authored peer-reviewed publications indexed in major scientific databases. The available metrics indicate four indexed documents, seventy-three citations, and an h-index of three. Research themes encompass developmental genetics, liver biology, transgenic technologies, and regenerative mechanisms, reflecting a consistent commitment to experimentally driven biological inquiry.[1]

Research Contributions

Among Zhu’s notable contributions is the characterization of liver-enriched gene family members essential for normal liver development in zebrafish, expanding knowledge of organogenesis and developmental regulation.[2] Additional investigations examined expression patterns of homologous genes in mammalian systems, providing comparative biological insights.[3] Research on Def haploinsufficiency demonstrated activation of p53-dependent TGFβ signaling during regenerative responses, revealing mechanisms associated with scar formation following partial hepatectomy.[4] Zhu also contributed to transgenic zebrafish methodologies supporting functional genomic analysis of candidate genes involved in tumor pathogenesis.[5]

Publications

  • Chang CQ et al. (2011). Liver-enriched gene 1a and 1b encode novel secretory proteins essential for normal liver development in zebrafish.
  • Zhu ZH et al. (2012). Analysis of expression pattern of zebrafish leg1 homologous gene mu-leg1 in mouse.
  • Zhu ZH et al. (2014). Haploinsufficiency of Def activates p53-dependent TGFβ signalling and causes scar formation after partial hepatectomy.
  • Ung CY et al. (2015). Mosaic zebrafish transgenesis for functional genomic analysis of cooperative genes in tumor pathogenesis.
  • Gao C et al. (2018). Hepatocytes in a normal adult liver are derived solely from embryonic hepatocytes.

Research Impact

The research portfolio has contributed valuable evidence regarding developmental pathways, tissue regeneration, and cellular lineage tracing. These findings support broader scientific efforts aimed at understanding disease mechanisms and regenerative therapies. The citation record further indicates continued scholarly engagement with the published findings, particularly in developmental and translational biology disciplines.[1][6]

Award Suitability

Zhu’s record demonstrates sustained contributions to biological research through original investigations, methodological development, and collaborative scientific output. The integration of developmental genetics and regenerative biology aligns with the objectives of the International Research Awards on Cardiology & Cardiovascular Medicine, particularly where fundamental biological discoveries inform future therapeutic and translational applications.[5]

Conclusion

Zhi-Hui Zhu’s scholarly contributions reflect a focused research trajectory in developmental and regenerative biology. Through investigations involving gene regulation, organ development, and cellular regeneration, the researcher has advanced scientific understanding of biological processes relevant to health and disease. The documented body of work provides a credible basis for recognition through an academic research award program.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Zhi-Hui Zhu, Author ID 57199280440. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57199280440
  2. Chang CQ, Hu MJ, Zhu ZH, et al. (2011). Liver-enriched gene 1a and 1b Encode Novel Secretory Proteins Essential for Normal Liver Development in Zebrafish. PLoS ONE.
    https://doi.org/10.1371/journal.pone.0022910
  3. Zhu ZH, Hu MJ, Chang CQ, Peng JR. (2012). Analysis of expression pattern of zebrafish leg1 homologous gene mu-leg1 in mouse. Hereditas.
  4. Zhu ZH, Chen J, Xiong JW, Peng JR. (2014). Haploinsufficiency of Def Activates p53-Dependent TGFβ Signalling and Causes Scar Formation after Partial Hepatectomy. PLoS ONE.
    https://doi.org/10.1371/journal.pone.0096576
  5. Ung CY, Guo F, Zhang X, Zhu Z, Zhu S. (2015). Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis. Journal of Visualized Experiments.
    https://doi.org/10.3791/52567
  6. Gao C, Zhu Z, Gao Y, et al. (2018). Hepatocytes in a Normal Adult Liver Are Derived Solely from the Embryonic Hepatocytes. Journal of Genetics and Genomics.
    https://doi.org/10.1016/j.jgg.2017.12.003

Xinke Wang | Heart Failure | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Ms. Xinke Wang | Heart Failure | Best Researcher Award

China Medical University | China

Ms. Xinke Wang is a dedicated researcher and master’s scholar at China Medical University, specializing in cardiovascular diseases with a particular focus on heart failure. Her academic background integrates clinical and epidemiological research, emphasizing the translation of basic scientific discoveries into effective clinical applications. Through her work, she strives to elucidate novel mechanisms underlying heart failure progression and identify innovative therapeutic strategies to improve patient care and outcomes. Ms. Wang has contributed significantly to various aspects of research, including data curation, conceptualization, methodology design, software development, formal analysis, validation, and manuscript preparation. Her ability to bridge clinical insight with analytical expertise underscores her commitment to advancing cardiovascular medicine. Collaborating with esteemed institutions such as Kailuan General Hospital, she actively engages in multidisciplinary research aimed at improving diagnostic precision and treatment efficacy in heart failure management. Her growing body of work reflects both academic rigor and practical relevance, contributing to the evolving landscape of cardiovascular research. Ms. Wang’s scholarly efforts exemplify a strong dedication to medical innovation, evidence-based practice, and collaborative science. By combining her expertise in epidemiology with a passion for clinical application, she continues to advance the understanding of cardiovascular health and disease, fostering new approaches that hold promise for enhancing patient outcomes and shaping the future of cardiovascular research.

Profile: Orcid

Featured Publication

Wang, X., Ning, N., Li, Y., Huang, R., Liu, Y., Miao, Y., Zhang, W., Chen, S., Gao, J., Wu, S., et al. (2025). Association of scores on the Life’s Essential 8 scale with progression to type 2 diabetes, heart failure, and death: A multistate Markov model analysis. Maturitas.

Thilini Jayasinghe | Cardiovascular Researches | Best Research Article Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Thilini Jayasinghe | Cardiovascular Researches | Best Research Article Award

The Univeristy of Sydney | Australia

Dr. Thilini Jayasinghe is a dedicated and forward-thinking early-career researcher specializing in the complex interplay between the oral and gut microbiomes, inflammation, and nutrition in chronic disease contexts. She has authored 25 documents, comprising peer-reviewed publications, book chapters, and research articles, which have collectively accumulated 474 citations, reflecting the significance and reach of her work within the scientific community. Her research achievements are further highlighted by an h-index of 11, demonstrating both productivity and impact. Over the past eight years, Dr. Jayasinghe has contributed to and led multidisciplinary studies spanning epidemiological, clinical, and pre-clinical models, collaborating with teams across eight countries, with more than half of her publications arising from international partnerships. She has successfully secured competitive research grants and played a pivotal role in ethics submissions, clinical trial protocols, and biobank initiatives. Her technical expertise encompasses molecular microbiology, bioinformatics, multi-omics integration, animal model research, and clinical trial design, alongside strong project leadership and mentorship skills. Currently serving as a Research Fellow at the University of Sydney, she leads translational research projects, supervises students at various academic levels, and contributes to teaching programs. Dr. Jayasinghe’s work continues to advance understanding of diet–microbiome–inflammation interactions, aiming to improve human health outcomes globally.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

Wilson, B. C., Zuppi, M., Derraik, J. G. B., Albert, B. B., Tweedie-Cullen, R. Y., Leong, K. S. W., Beck, K. L., Vatanen, T., O’Sullivan, J. M., Cutfield, W. S., & on behalf of the Gut Bugs Study Group (including Jayasinghe, T.). (2025). Long-term health outcomes in adolescents with obesity treated with faecal microbiota transplantation: 4-year follow-up. Nature Communications, 16, 7786.

Jayasinghe, T., Jenkins, J., Medara, N., Choowong, P., Dharmarathne, G., Kong, F., Cho, H., Kim, S. H., Zhang, Y. G., Franco-Duarte, R., Eberhard, J., & Spahr, A. (2025). Dietary fibre modulates body composition, blood glucose, inflammation, microbiome, and metabolome in a murine model of periodontitis. Nutrients, 17(7), 1146.

Dharmarathne, G., Kazi, S., King, S., & Jayasinghe, T. N. (2024). The bidirectional relationship between cardiovascular medications and oral and gut microbiome health: A comprehensive review. Microorganisms, 12, 2246.

Jayasinghe, T. N., & Spahr, A. (2023). Dietary supplementation of omega-3 fatty acids could be used as an adjunct therapy to nonsurgical periodontal treatment. Journal of Evidence-Based Dental Practice, 101925.

Chopra, A., Jayasinghe, T. N., & Eberhard, J. (2022). Are inflamed periodontal tissues endogenous source of advanced glycation end-products (AGEs) in individuals with and without diabetes mellitus? A systematic review. Biomolecules, 12, 642.

 

Wei Eric Wang | Myocardial Infarction | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Wei Eric Wang | Myocardial Infarction | Best Researcher Award

Prof. Wei Eric Wang, Southwest Hospital, Army Medical University, China

Prof. Wei Eric Wang is a distinguished medical professional based at Southwest Hospital, Army Medical University, in China. Renowned for his expertise in medical research and clinical practice, he has contributed significantly to the fields of surgery, healthcare management, and medical education. With numerous publications in peer-reviewed journals, Prof. Wang has established a reputation for pioneering studies in his area of specialization. He is also actively involved in advancing medical training, and his leadership at the hospital continues to shape healthcare innovation in China. His work has earned him recognition both nationally and internationally.

AUTHOR PROFILE

Scopus

Orcid

🎓EARLY ACADEMIC PURSUITS:

Dr. Wei (Eric) Wang pursued his medical education at the Third Military Medical University in Chongqing, China. He earned his M.D. in Clinical Medicine from 2000 to 2005. Following this, he completed his Ph.D. at the Institute of Burn Surgery, Southwest Hospital, at the same university between 2005 and 2010. His early academic endeavors laid the foundation for his expertise in cardiology and geriatric medicine.

🏥PROFESSIONAL ENDEAVORS:

Dr. Wang has held various prestigious positions throughout his career. He has been the Director of the Department of Geriatrics at Southwest Hospital since November 2022, demonstrating his leadership in the field. Prior to this, he served as Chief Physician and Professor in the Department of Cardiology at Daping Hospital, Army Medical University. His extensive experience includes roles such as Deputy Director, Associate Chief Physician, Attending Doctor, and Resident, reflecting his progressive career growth and expertise in cardiology and geriatrics.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON Myocardial Infarction

Dr. Wang’s research is centered on new strategies for treating cardiovascular diseases, particularly myocardial infarction and heart failure. His primary areas of focus include:

  1. Mechanisms regulating cardiac regeneration.
  2. Translational and clinical studies for treating cardiovascular diseases.
  3. Translational and clinical research for preventing aging.

His work has significantly advanced the understanding of cardiac repair mechanisms and potential therapeutic interventions.

🌍IMPACT AND INFLUENCE:

Dr. Wang has played a crucial role in the field of cardiology and geriatrics. His research has contributed to innovative treatments that enhance cardiac regeneration and improve patient outcomes. As a leader in cardiovascular medicine, his influence extends beyond clinical practice to shaping future medical research and treatment methodologies.

📚ACADEMIC CITATIONS AND RECOGNITION:

Dr. Wang has an impressive list of publications in esteemed medical journals. Some of his notable works include:

  1. “Metabolic reprogramming: a byproduct or a driver of cardiomyocyte proliferation?” published in Circulation (2024).
  2. “Loss of NPPA-AS1 promotes heart regeneration by stabilizing SFPQ-NONO heteromer-induced DNA repair,” published in Basic Research in Cardiology (2022).
  3. “The Role of G Protein-Coupled Receptor Kinase 4 in Cardiomyocyte Injury after Myocardial Infarction,” published in European Heart Journal (2021).
  4. “Dedifferentiation, Proliferation, and Redifferentiation of Adult Mammalian Cardiomyocytes After Ischemic Injury,” published in Circulation (2017).

These publications highlight his extensive contributions to cardiovascular research and his role in advancing medical knowledge in this domain.

🌟LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Wang’s legacy is deeply rooted in his contributions to cardiovascular research, innovative treatment strategies, and leadership in geriatric medicine. As a distinguished professor and researcher, his work continues to shape the future of cardiology and geriatrics. His ongoing research and clinical innovations are expected to provide new breakthroughs in cardiac care and aging prevention, benefiting future generations of patients and medical professionals.

🚀CONCLUSION:

Prof. Wei Eric Wang is a distinguished cardiologist and geriatrician whose groundbreaking research and leadership have significantly impacted cardiovascular medicine. His dedication to innovation, patient care, and scientific discovery continues to inspire future generations. As Director of Geriatrics at Southwest Hospital, his work advances both clinical and translational medicine, improving lives worldwide. With numerous influential publications and a commitment to pioneering treatments, his contributions to cardiac regeneration and aging prevention are invaluable. His legacy in medicine and academia ensures a lasting impact, shaping the future of healthcare and research.

TOP NOTABLE PUBLICATIONS

  • Title: Metabolic Reprogramming: A Byproduct or a Driver of Cardiomyocyte Proliferation?
    Authors: Xiaokang Chen, Hao Wu, Ya Liu, Lingyan Liu, Steven R. Houser, Wei Eric Wang
    Journal: Circulation
    Year: 2024

  • Title: Loss of NPPA-AS1 promotes heart regeneration by stabilizing SFPQ–NONO heteromer-induced DNA repair
    Authors: Wenbin Fu, Hongmei Ren, Jialing Shou, Qiao Liao, Liangpeng Li, Yu Shi, Pedro A. Jose, Chunyu Zeng, Wei Eric Wang
    Journal: Basic Research in Cardiology
    Year: 2022

  • Title: The Protective Role of Yin‐Yang 1 in Cardiac Injury and Remodeling After Myocardial Infarction
    Authors: Yu Huang, Liangpeng Li, Hongmei Chen, Qiao Liao, Xiaoli Yang, Dezhong Yang, Xuewei Xia, Hongyong Wang, Wei Eric Wang, Lianglong Chen et al.
    Journal: Journal of the American Heart Association
    Year: 2021

  • Title: The role of G protein-coupled receptor kinase 4 in cardiomyocyte injury after myocardial infarction
    Authors: Wei Eric Wang, Liangpeng Li, Fu W, Gong X, Chen Z, Tang L, Yang D, Liao Q, Xia X, Wu H et al.
    Journal: European Heart Journal
    Year: 2021

  • Title: An Aurora Kinase B-Based Mouse System to Efficiently Identify and Analyze Proliferating Cardiomyocytes
    Authors: Wei Eric Wang, Fu W, Liao Q, Li L, Shi Y, Zeng A, Zeng C, Wang WE
    Journal: Frontiers in Cell and Developmental Biology
    Year: 2020

  • Title: Cardiomyocyte PKA Ablation Enhances Basal Contractility While Eliminates Cardiac β-Adrenergic Response Without Adverse Effects on the Heart
    Authors: Wei Eric Wang, Zhang Y, Wang WE, Zhang X, Li Y, Chen B, Liu C, Ai X, Zhang X, Tian Y et al.
    Journal: Circulation Research
    Year: 2019

  • Title: Noncoding RNA and Cardiomyocyte Proliferation
    Authors: Shuang Qu, Chunyu Zeng, Wei Eric Wang
    Journal: Stem Cells International
    Year: 2017

  • Title: Dedifferentiation, Proliferation, and Redifferentiation of Adult Mammalian Cardiomyocytes After Ischemic Injury
    Authors: Wei Eric Wang, Wang WE, Li L, Xia X, Fu W, Liao Q, Lan C, Yang D, Chen H, Yue R et al.
    Journal: Circulation
    Year: 2017

  • Title: Prolyl hydroxylase domain protein 2 silencing enhances the survival and paracrine function of transplanted adipose-derived stem cells in infarcted myocardium
    Authors: Wei Eric Wang, Wang WE, Yang D, Li L, Wang W, Peng Y, Chen C, Chen P, Xia X, Wang H et al.
    Journal: Circulation Research
    Year: 2013